The binding of polypeptide growth factors to their appropriate cell surface transmembrane receptors triggers numerous biochemical responses, including the transcriptional activation of specific genes. We have used a differential display approach to identify fibroblast growth factor-1-inducible genes in murine NIH 3T3 cells. Here, we report that the fibroblast growth factorinducible-14 (Fn14) gene is a growth factor-regulated, immediate-early response gene expressed in a developmental stage-and adult tissue-specific manner in vivo. This gene, located on mouse chromosome 17, is predicted to encode an 129-amino acid type Ia membrane protein with no significant sequence similarity to any known protein. We have used two experimental approaches, direct fluorescence microscopy and immunoprecipitation analysis of biotinylated cell surface proteins, to demonstrate that Fn14 is located on the plasma membrane. To examine the biological consequences of constitutive Fn14 expression, we isolated NIH 3T3 cell lines expressing variable levels of epitope-tagged Fn14 and analyzed their phenotypic properties in vitro. These experiments revealed that Fn14 expression decreased cellular adhesion to the extracellular matrix proteins fibronectin and vitronectin and also reduced serum-stimulated cell growth and migration. These results indicate that Fn14 is a novel plasma membrane-spanning molecule that may play a role in cell-matrix interactions.Complex cellular processes such as proliferation, migration, differentiation, and apoptosis are regulated in part by a diverse group of molecules known as polypeptide growth factors. These factors act by binding and thereby activating specific transmembrane receptor tyrosine kinases. The activation of cell surface receptors by polypeptide ligands triggers downstream intracellular events, including the stimulation of protein phosphorylation cascades and the transcriptional activation of numerous genes (1, 2). Many mitogen-inducible genes have been identified, and they encode a diverse group of proteins including transcription factors, protein kinases and phosphatases, cell cycle regulators, and cytoskeletal and extracellular matrix proteins (2, 3). A recent study using cDNA microarray technology has demonstrated that Ͼ500 genes are transcriptionally activated after serum stimulation of quiescent human fibroblasts and that a subset of these genes encode proteins implicated in the wound healing process in vivo (3).Our laboratory has been studying fibroblast growth factor-1 (FGF-1) 1 -regulated gene expression in murine NIH 3T3 cells. FGF-1 (also referred to as acidic FGF) is one of the most extensively characterized members of the FGF family of heparin-binding proteins (4 -6). It is a potent mitogenic, chemotactic, angiogenic, and neurotrophic factor both in vitro and in vivo. These cellular responses are mediated via high affinity binding to a family of related membrane-spanning tyrosine kinase receptors (4 -6). We have shown by Northern blot hybridization analysis that FGF-1 stimulation of quies...
Chronic incubation of 3T3-L1 adipocytes with tumor necrosis factor (TNF) induces a state of insulin resistance characterized by a diminished ability of insulin to induce phosphorylation of the beta subunit of its own receptor and insulin receptor substrate 1 (IRS-1). When adipocytes are briefly pretreated with TNF and then stimulated with insulin, tyrosine phosphorylation of IRS-1 increases above the level induced by insulin alone. By itself, TNF induces the time-dependent tyrosine phosphorylation of proteins in 3T3-L1 adipocytes. Among these is IRS-1, a docking protein with tyrosine phosphorylation sites that bind cytoplasmic signaling molecules that contain Src homology 2 (SH2) domains. TNF stimulation of 3T3-L1 adipocytes also promotes the association of the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase) with IRS-1 and also its tyrosine phosphorylation. In murine 3T3-L1 adipocytes, IRS-1 and PI 3-kinase phosphorylation and the association of these proteins are promoted by murine TNF, which interacts with the type 1 and type 2 TNF receptors. Human TNF, which binds to the murine type 1 TNF receptor selectively, also promotes IRS-1 phosphorylation and binding of IRS-1 to PI 3-kinase. This is the first demonstration that a member of the TNF/nerve growth factor receptor superfamily can use an IRS-1 signaling system as a component of its cellular response and provides a mechanism through which TNF receptors may engage downstream elements in signaling pathways.
Aldose reductase (AR) is an NADPH-dependent aldo-keto reductase implicated in cellular osmoregulation and detoxification. Two distinct murine genes have been identified that are predicted to encode proteins with significant amino acid sequence identity with mouse AR: mouse vas deferens protein and fibroblast growth factor (FGF)-regulated-1 protein (FR-1). Here we report that the AR and FR-1 genes are differentially regulated in NIH 3T3 fibroblasts. FGF-1 stimulation of quiescent cells induces both AR and FR-1 mRNA levels, but the effect on FR-1 mRNA expression is significantly greater. FGF-1 treatment also increases FR-1 protein expression, as determined by Western-blot analysis using FR-1-specific polyclonal antiserum. Calf serum stimulation of quiescent cells increases AR mRNA expression but not FR-1 mRNA expression. Finally, when NIH 3T3 cells are grown in hypertonic medium, AR mRNA levels are significantly increased whereas FR-1 mRNA levels are only slightly up-regulated. These results indicate that the AR and FR-1 genes are differentially regulated in murine fibroblasts by two different growth-promoting agents and by hyperosmotic stress. Therefore these structurally related enzymes may have at least some distinct cellular functions; for example, although both AR and FR-1 activity may be important for the metabolic changes associated with cellular proliferation, AR may be the primary aldo-keto reductase involved in cellular osmoregulation.
Polypeptide growth factors promote cellular proliferation by binding to specific plasma membrane-anchored receptors. This interaction triggers the phosphorylation of signal transducing molecules and the transcriptional activation of numerous genes. We have used a differential display approach to identify fibroblast growth factor (FGF)-1-inducible genes in murine NIH 3T3 fibroblasts. Here we report that one of these genes encodes ank, a type IIIa transmembrane protein reported to function in cells as an inorganic pyrophosphate transporter. FGF-1 induction of ank mRNA expression is first detectable at 2 h after growth factor addition and is dependent on de novo RNA and protein synthesis. Ank gene expression is also upregulated after treating quiescent fibroblasts with several other mitogenic agents (e.g., calf serum or platelet-derived growth factor-BB) or the tumor promoter phorbol 12-myristate 13-acetate. Furthermore, in comparison to parental NIH 3T3 cells, oncogene-transformed NIH 3T3 cells constitutively express elevated levels of ank mRNA. FGF-1 also increases ank gene expression in non-immortalized human embryonic lung fibroblasts. Finally, the murine and human ank genes are expressed in vivo in a tissue-specific manner, with highest levels of mRNA expression found in brain, heart, and skeletal muscle. These results indicate that ank is a growth factor-regulated delayed-early response gene in mammalian cells, and we propose that increased ank expression during cell cycle progression may be necessary to maintain proper intracellular pyrophosphate levels during conditions of high cellular metabolic activity.
We have constructed in-frame lacZ protein fusions to the first three genes of the Escherichia coli unc operon, which codes for the subunits of the proton-translocating ATPase. We have used these constructions to measure the relative in vivo expression of these genes. The second and third genes, uncB and uncE, which code for the a and c subunits of the Fo sector, were expressed at relative levels of approximately 1:10, although the measured expression of uncB depended upon how much of the gene was fused to lacZ. These rates compared favorably with the relative numbers of a and c subunits (a1:cjO) in the purified F1Fo complex. The in vivo expression of uncI, the first gene of the operon, was very low, at best 10 to 20 times less than the expression of uncB. (10,21,22).The genes which code for the eight subunits of the ATPase are contained within the unc operon, located at 83.5 min on the E. coli chromosome. The unc operon actually consists of nine genes which are transcribed in the order uncl, -B, -E, -F, -H, -A, -G, -D, and -C, corresponding to protein i and subunits a, c, b, 8, a(, y, P, and r, respectively. The role of protein i is currently not known, but it has been shown that this protein is not required for the activity or biosynthesis of the ATPase complex (11,28).Each gene exists in a single copy within the operon, and the operop is transcribed into a single polycistronic mRNA, yet the subunits encoded by these genes exist in different numbers in the assembled complex. Particularly intriguing is the stoichiometry of the a and c subunits of the Fo sector, which has been determined to be 1:10 (7). This unusual stoichiometry raises questions about the regulation of gene expression. Results from studies on the synthesis of ATPase polypeptides in vivo using minicells, in vitro in a transcription-translation system, or in UV-irradiated X unc lysogens indicate that the a and c subunits are synthesized differentially (4, 18). It appears that in order for the subunits to be synthesized in the appropriate relative amounts, there must be some sort of regulation, probably at the level of translation, which would allow for the expression of uncE to * Corresponding author. t Present address: E. I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898. increase over that of uncB. The exact mechanism of control over the apparent differences in expression exhibited by these genes is currently unknown. McCarthy and coworkers, however, have demonstrated that an RNA sequence within the translational initiation region of uncE causes increased synthesis of the c subunit (15) and can also increase the expression of other genes when located within the translation initiation region of those genes (16). This sequence, therefore, appears to enhance expression of uncE.This research was aimed at quantitating the in vivo expression of the first three genes of the E. coli unc operon. A series of lacZ protein fusions were constructed in uncI, uncB, and uncE, and the relative level of expression of each gene was determined by comparin...
The acidic fibroblast growth factor (aFGF) and basic fibroblast growth factor (bFGF) proteins are potent vascular smooth muscle cell (SMC) mitogens that are expressed by endothelial cells and SMCs in vivo. Overexpression of these proteins in transfected cell lines can result in autocrine transformation; therefore, the precise control of fibroblast growth factor gene expression in the vessel wall may be an important mechanism regulating vascular cell growth. In the present study, we demonstrate that bFGF can induce bFGF mRNA expression, but not aFGF mRNA expression, in serum-starved rat aortic SMCs. bFGF autoinduction is maximal at 4 hours, requires de novo RNA and protein synthesis, and is mediated predominantly by a protein kinase C-dependent signaling pathway. Furthermore, aFGF treatment of rat SMCs also increases bFGF mRNA and protein expression; however, aFGF mRNA levels are only slightly modulated. These results suggest that the local release of aFGF or bFGF within the vessel wall could promote a prolonged period of elevated bFGF synthesis. This, in turn, could be of importance in the SMC hyperplasia that occurs in response to vascular injury and during atherosclerotic plaque formation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.